You are here: Industry Insights > Sputnik V vaccine

News List

India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine firstwordpharma
August 06, 2021
Panacea Biotec has agreed to produce up to 25 million doses of Russia’s Sputnik V COVID-19 vaccine using the drug substance made by Generium, as reported by Yahoo!News.
Dr Reddy’s announces arrival of first consignment of Sputnik V vaccine in India expresspharma
May 06, 2021
The rollout of the consignment will be subject to the necessary clearances, which will be processed over the next few days.
Algeria registers Russian Sputnik V vaccine against Covid-19 pharmaceutical-technology
January 12, 2021
The Russian Direct Investment Fund (RDIF) has announced the registration of Sputnik V vaccine against Covid-19 by the National Agency of Pharmaceutical Products of People’s Democratic Republic of Algeria.
AstraZeneca to test combination of AZD1222 and Sputnik V vaccines europeanpharmaceuticalreview
December 15, 2020
AstraZeneca will begin testing whether they can improve the efficacy of AZD1222 by combining it with the Ad26 human adenoviral vector from Russia’s Sputnik V vaccine.
Sputnik V vaccine efficacy is 91.4 per cent: RDIF, Gamaleya Center expresspharma
December 15, 2020
Based on the data obtained at the third control point, the Gamaleya Center will create a report that will be used to submit for accelerated registration of the Sputnik V vaccine in various countries.
Dr Reddy’s and RDIF begin clinical trials for Sputnik V vaccine in India expresspharma
December 02, 2020
The clinical trials are being conducted by JSS Medical Research as the clinical research partner.
RDIF and Hetero agree to produce over 100 million doses of Sputnik V vaccine in India expresspharma
November 27, 2020
The parties intend to start the production of Sputnik V in the beginning of 2021.
The cost of one dose of the Sputnik V vaccine will be less than $10 for international markets prnasia
November 26, 2020
The Russian Direct Investment Fund announces the cost of the Russian Sputnik V vaccine for international markets will be less than $10 per dose starting from February 2021, which is less than $20 for the two doses necessary to vaccinate one person.
Sputnik V COVID-19 vaccine over 90 percent effective, interim data shows europeanpharmaceuticalreview
November 26, 2020
Phase III trial interim data has shown that Russia’s COVID-19 vaccine candidate, Sputnik V, is 91.4 percent effective.
India, China may start producing Sputnik V vaccine: Putin expresspharma
November 18, 2020
Putin also proposed that the creation of a vaccine research centre for BRICS countries be sped up.

Previous page 1 2 Next page